{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:01:39Z","timestamp":1790344899425,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.lungcan.2026.109517","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:32:50Z","timestamp":1782948770000},"page":"109517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clonal divergence with acquired BRAF V600E in NSCLC with compound EGFR G719X\/S768I after prolonged EGFR-TKI therapy"],"prefix":"10.1016","volume":"218","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2846-9969","authenticated-orcid":false,"given":"Camilla","family":"Hviid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linea C.","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siv M.S.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan O.","family":"L\u00f6fgren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Santoni-Rugiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4578-9346","authenticated-orcid":false,"given":"Edyta M.","family":"Urbanska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lungcan.2026.109517_b0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.annonc.2022.03.010","article-title":"Classification of atypical EGFR mutations in non-small-cell lung cancer","volume":"33","author":"Rosell","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.lungcan.2026.109517_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jtho.2024.03.016","article-title":"Unveiling the landscape of uncommon EGFR mutations in NSCLC: a systematic review","volume":"19","author":"Borgeaud","year":"2024","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109517_b0015","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41586-021-03898-1","article-title":"Structure-based classification predicts drug response in EGFR-mutant NSCLC","volume":"597","author":"Robichaux","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.lungcan.2026.109517_b0020","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jtho.2016.11.2231","article-title":"Acquired BRAF V600E mutation as a resistance mechanism after treatment with osimertinib","volume":"12","author":"Ho","year":"2017","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2026.109517_b0025","first-page":"568","article-title":"Concurrent alterations in EGFR-mutant lung cancers associated with resistance to osimertinib","volume":"10","author":"Yu","year":"2020","journal-title":"Cancer Discov."},{"key":"10.1016\/j.lungcan.2026.109517_b0030","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/s41698-021-00241-9","article-title":"Clonal dynamics of BRAF-driven drug resistance in EGFR-mutant lung cancer","volume":"5","author":"Schaufler","year":"2021","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.lungcan.2026.109517_b0035","article-title":"Afatinib for the treatment of non-small cell lung cancer harboring uncommon EGFR mutations: an updated database of 1023 cases. Front","volume":"12","author":"Yang","year":"2022","journal-title":"Oncol"},{"issue":"3","key":"10.1016\/j.lungcan.2026.109517_b0040","article-title":"Osimertinib in NSCLC with atypical EGFR\u2013activating mutations: a retrospective multicenter study","volume":"4","author":"Ji","year":"2023","journal-title":"JTO Clin Res Rep."},{"key":"10.1016\/j.lungcan.2026.109517_b0045","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.21037\/jtd-23-629","article-title":"Efficacy and tolerability of osimertinib with dabrafenib and trametinib in BRAF V600E-acquired EGFR-mutant NSCLC: a case series","volume":"16","author":"Lu","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.lungcan.2026.109517_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.103935","article-title":"Features and efficacy of triple-targeted therapy for EGFR-mutant NSCLC with acquired BRAF alterations","volume":"9","author":"Li","year":"2024","journal-title":"ESMO Open"},{"key":"10.1016\/j.lungcan.2026.109517_b0055","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41586-026-10428-4","article-title":"Evolutionary characterization of lung cancer metastasis","volume":"653","author":"Hessey","year":"2026","journal-title":"Nature"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500226005787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:27:23Z","timestamp":1790342843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500226005787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":11,"alternative-id":["S0169500226005787"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109517","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clonal divergence with acquired BRAF V600E in NSCLC with compound EGFR G719X\/S768I after prolonged EGFR-TKI therapy","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2026.109517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109517"}}